Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer
Christoph A. Fink(Heidelberg University), Juliane Hörner‐Rieber(Düsseldorf University Hospital), Jakob Liermann(Heidelberg University), David Bonekamp(Heidelberg University), Carolin Buchele(Heidelberg University), Lukas Baumann(Statistics Austria), Laila König(Heidelberg University), Sebastian Klüter(Heidelberg University), Elisabetta Sandrini(Heidelberg University), Carolin Rippke(Heidelberg University), Jonas Ristau(Heidelberg University), Stefan A. Koerber(German Cancer Research Center), Jürgen Debus(Heidelberg University), Heinz‐Peter Schlemmer(German Cancer Research Center), Philipp Hoegen(German Cancer Research Center), Sebastian Regnery(Heidelberg University)
Cited by 10
Related Papers
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
|The Lancet Oncology|2024|305
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
|Journal of the American Society of Nephrology|2017|302
Assessing the predictability of <i>IDH</i> mutation and <i>MGMT</i> methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T
|Neuro-Oncology|2018|168
Downfield‐NOE‐suppressed amide‐CEST‐MRI at 7 Tesla provides a unique contrast in human glioblastoma
|Magnetic Resonance in Medicine|2016|133
Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood
|Clinical Microbiology and Infection|2009|121